- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Improving Treatment Adherence
David May, MD, PhD, FACC, explores strategies that can improve rates of adherence to treatment among patients with cardiovascular conditions. Dr May explains that it is important for all professionals involved in a patient’s care to assess and reinforce the patient’s knowledge base, and notes that this can improve adherence rates.
Additionally, Dr May notes that electronic reminder systems and mobile apps can help remind patients and their family members when it is time to take medication. Simplified dosing regimens can also improve treatment adherence, says Dr May.
In addition to communication techniques, electronic reminder systems, and mobile apps, Dr May discusses how the use of newer oral anticoagulants, such as rivaroxaban, apixaban, and dabigatran, can enhance care for patients with cardiovascular conditions. He notes that prior to the introduction of these newer agents, treatment options either required routine blood tests or were administered via injection. In contrast, routine blood tests are not required with the newer oral anticoagulants, and this may lead to better adherence outcomes.
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
